Royal Bank of Canada’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-700,000
Closed -$5.36M 7168
2024
Q3
$5.36M Buy
+700,000
New +$6.45M ﹤0.01% 2232
2022
Q2
Sell
-500,000
Closed -$7.74M 7644
2022
Q1
$7.74M Buy
+500,000
New +$6.31M ﹤0.01% 1907
2016
Q1
Sell
-93,300
Closed -$1.41M 6587
2015
Q4
$1.41M Hold
93,300
﹤0.01% 2827
2015
Q3
$1.23M Buy
+93,300
New +$1.48M ﹤0.01% 2687
2014
Q1
Sell
-40,000
Closed -$1.01M 6096
2013
Q4
$1.01M Buy
+40,000
New +$957K ﹤0.01% 2824

Other funds holding PTEN

Royal Bank of Canada's PTEN Position: Q1 2026 in Review

Royal Bank of Canada increased its Patterson-UTI (PTEN) stake by 12% in Q1 2026, buying an estimated $118K and bringing the position to 124,588 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3397.

Royal Bank of Canada first reported a position in PTEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.6M in Q1 2014. 412 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Royal Bank of Canada held 124,588 shares of Patterson-UTI worth $1.35M as of Q1 2026.
  • Royal Bank of Canada bought 13,790 Patterson-UTI shares in Q1 2026, an estimated $118K.
  • Patterson-UTI made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3397 holding.
  • Royal Bank of Canada first reported a position in Patterson-UTI in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Patterson-UTI position peaked at $45.6M in Q1 2014.
  • 412 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.